VEGFA and diabetic retinopathy: Kaba et al.’s prospective cohort study noted that OSAS may diminish the efficacy of intravitreal anti-VEGF treatment due to higher serum levels of VEGF observed in patients with diabetic retinopathy and concurrent OSAS, implying a multifactorial influence [5].